Lotus Eye Hospital passes all AGM resolutions; scrutinizer report released

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • All four resolutions at Lotus Eye Hospital's 29th AGM passed with requisite majorities
  • Adoption of FY26 financial statements received 99.39% votes in favour
  • Re-appointment of Dr. Kavetha Sundaramoorthy approved with 81.27% support
  • Remuneration revision for MD Sangeetha Sundaramoorthy passed with 76.43% votes
powered bylight_fuzz_icon
51719890

*this image is generated using AI for illustrative purposes only.

Lotus Eye Hospital and Institute Limited concluded its 29th Annual General Meeting on September 23, 2026, with all four proposed resolutions passing with requisite majorities. The Consolidated Scrutinizer's Report was submitted on September 24, 2026, confirming the voting outcomes for the meeting held via Video Conferencing/Other Audio Visual Means (VC/OAVM).

Meeting proceedings

The meeting commenced at 4:00 pm and concluded at 4:25 pm. Dr. Kavetha Sundaramoorthy, Chairperson, presided over the session. All directors of the company attended the meeting. The requisite quorum was present, allowing the Chairperson to call the meeting to order.

The Managing Director briefed shareholders on the services provided by the company and other significant aspects of its business operations. Subsequently, the Chief Financial Officer presented the financial highlights for the financial year 2025-26 (FY26).

Governance and audit status

Key governance updates included:

  • The Statutory Auditors issued an unmodified audit report for FY26.
  • Qualifications contained in the Secretarial Audit Report were duly addressed by the Management.
  • Appropriate responses to these qualifications were provided in the Board's Report.
  • The items of business contained in the AGM Notice were taken as read with shareholder permission.

Voting results summary

The e-voting facility remained open for a further period of 30 minutes after the discussion concluded. The following table summarizes the voting outcomes for the four resolutions passed during the 29th AGM:

Resolution Type Description Votes For (%) Votes Against (%) Result
Item No. 1 Ordinary Adoption of FY26 Financial Statements 99.39% 0.61% Passed
Item No. 2 Ordinary Re-appointment of Dr. Kavetha Sundaramoorthy 81.27% 18.73% Passed
Item No. 3 Ordinary Revision in remuneration of Ms. Sangeetha Sundaramoorthy 76.43% 23.57% Passed
Item No. 4 Special Continuation of remuneration to Dr. K.S. Ramalingam 94.54% 5.46% Passed

Shareholder engagement

Shareholders were given an opportunity to speak and raise queries during the meeting. Out of three shareholders who registered to speak, only one was present. The questions raised by this shareholder were duly addressed by the Chief Financial Officer.

The Scrutinizer, P. Eswaramoorthy of P. Eswaramoorthy and Company, Company Secretaries, confirmed that the remote e-voting period ran from September 20, 2026, to September 22, 2026. Shareholders holding shares as of the cut-off date, September 16, 2026, were entitled to vote. The electronic voting system provided by Central Depository Services (India) Limited (CDSL) ensured that no shareholder voted more than once.

The Chairperson thanked all shareholders for their participation before declaring the meeting closed. The scrutinizer's records remain in safe custody until the minutes are approved and signed.

Historical Stock Returns for Lotus Eye Hospital

1 Day5 Days1 Month6 Months1 Year5 Years
+4.53%+0.37%+3.41%+5.30%-6.55%0.0%

How might the 18.73% dissenting vote against Dr. Kavetha Sundaramoorthy's re-appointment influence future board composition or governance reforms at Lotus Eye Hospital?

What specific strategic initiatives or capital expenditures are outlined in the FY26 financial highlights that could drive growth for the company in the coming fiscal year?

Given the Secretarial Audit qualifications were addressed, what ongoing compliance measures will the management implement to prevent recurrence in the FY27 audit cycle?

Lotus Eye Hospital sets Sept 23 AGM for MD pay hike, director vote

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Lotus Eye Hospital schedules AGM on September 23, 2026, for MD pay hike
  • MD Sangeetha Sundaramoorthy's monthly salary proposed to rise to ₹6 lakh
  • FY26 revenue grew 8.4% to ₹5,371 lakh; PAT fell 89% to ₹8 lakh
  • New borrowings of ₹1,142 lakh taken for expansion; assets up 18.7%
  • Shareholders to reappoint Dr. Kavetha Sundaramoorthy by rotation
powered bylight_fuzz_icon
49794807

*this image is generated using AI for illustrative purposes only.

Lotus Eye Hospital has scheduled its 29th Annual General Meeting for September 23, 2026, to approve a significant increase in the Managing Director’s remuneration and the reappointment of a retiring director. The meeting will be conducted via video conferencing.

Shareholders will consider an ordinary resolution to raise Ms. Sangeetha Sundaramoorthy’s monthly salary from ₹3,50,000 to ₹6,00,000, effective August 10, 2026. This revision applies to her remaining tenure until August 14, 2028. The Board cited her contribution to growth and expansion plans as justification for the hike.

Governance Changes

The agenda also includes the reappointment of Dr. Kavetha Sundaramoorthy, who retires by rotation. Additionally, shareholders must pass a special resolution to continue paying Dr. Kuttapalayam Songappan Ramalingam a monthly remuneration of ₹1,00,000 for FY27. This approval is required under SEBI LODR regulations because his annual pay exceeds 50% of the total remuneration for all non-executive directors.

Financial Context

The company reported a turnover of ₹5,489.03 lakh and a profit after tax of ₹8.04 lakh for FY26. Revenue from operations grew 8.4% year-on-year to ₹5,371.41 lakh from ₹4,956.25 lakh in FY25. However, net profit declined sharply from ₹73.93 lakh in the previous year due to initial costs associated with new center investments, including a facility in Gobichettipalayam. Management expects these investments to improve margins in the long run.

Metric FY26 FY25 Change
Revenue from Operations ₹5,371.41 lakh ₹4,956.25 lakh +8.4%
Profit After Tax ₹8.04 lakh ₹73.93 lakh -89.1%
Total Assets ₹8,259.74 lakh ₹6,957.37 lakh +18.7%

What the Numbers Show

The proposed remuneration revision represents a 71% increase in the Managing Director’s monthly fixed emoluments. With the company reporting a PAT of just ₹8.04 lakh against a turnover of ₹5,489.03 lakh in FY26, the annualized cost of this hike (₹30 lakh per year) is substantial relative to current profitability levels. Furthermore, the company’s total borrowings increased significantly to ₹1,142.97 lakh from nil in the prior year, reflecting debt-funded expansion.

Voting Details

Remote e-voting will be available from September 20 to September 22, 2026. The record date for determining voting eligibility is September 16, 2026. Shareholders holding shares as on this date may cast votes electronically through CDSL.

Historical Stock Returns for Lotus Eye Hospital

1 Day5 Days1 Month6 Months1 Year5 Years
+4.53%+0.37%+3.41%+5.30%-6.55%0.0%

How will the 71% increase in the Managing Director's remuneration impact shareholder returns given the sharp 89% decline in PAT and current debt levels?

What specific performance metrics or revenue targets must the new Gobichettipalayam facility achieve to justify the initial investment costs that suppressed FY26 profits?

Will the significant rise in total borrowings to ₹1,142.97 lakh affect the company's interest coverage ratio and long-term financial stability during the expansion phase?

More News on Lotus Eye Hospital

1 Year Returns:-6.55%